STIMPulseControl Ancillary Speech Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSteffen Paschen
About this trial
Speech assessment is a substudy to the STIMPulseControl study (hereinafter referred to as the main study), where audio recordings of patients voices will be recorded as part of a speech analysis in the main study, for this optional ancillary study.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- bilateral high frequency deep brain stimulation of the subthalamic neucleus combined with best medical treatment according to widely accepted expert consensus paper
- best medical treatment for management of impulse control in Parkinson´s disease according to widely accepted expert consensus paper
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Steffen Paschen
Lead sponsor
University of Kiel
Sponsor institution
Czech Technical University in Prague
Collaborator
Insel Gruppe AG, University Hospital Bern
Collaborator
Philipps University Marburg
Collaborator
University Hospital Schleswig-Holstein
Collaborator
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Collaborator
Source ClinicalTrials.gov